COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • March 4th, 2022 • Aytu Biopharma, Inc • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September 7, 2022 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on September 7, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Aytu BioPharma, Inc., a Delaware corporation (the “Company”), up to __________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PREFUNDED COMMON STOCK PURCHASE WARRANTPrefunded Common Stock Purchase Warrant • March 4th, 2022 • Aytu Biopharma, Inc • Pharmaceutical preparations • New York
THIS PREFUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Original Issue Date (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Aytu BioPharma, Inc., a Delaware corporation (the “Company”), up to __________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
AYTU BIOPHARMA, INC. (a Delaware corporation) 3,030,000 Shares of Common Stock Pre-Funded Warrants to Purchase 3,030,000 Shares of Common Stock Warrants to Purchase 6,666,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 4th, 2022 • Aytu Biopharma, Inc • Pharmaceutical preparations • New York
